Hostname: page-component-cd9895bd7-gxg78 Total loading time: 0 Render date: 2024-12-26T21:23:23.072Z Has data issue: false hasContentIssue false
  • English
  • Français

p53 expression, Ki-67 status, and cell density have no prognostic significance in glioblastomas treated with radio-chemotherapy

Published online by Cambridge University Press:  27 September 2006

M.W. Gross ,
K. Nashwan ,
H.-D. Mennel  and
R. Engenhart-Cabillic
M.W. Gross
Affiliation:
Department of Radiotherapy and Radio-Oncology, University of Giessen and Marburg, Marburg, Germany
K. Nashwan
Affiliation:
Department of Radiotherapy and Radio-Oncology, University of Giessen and Marburg, Marburg, Germany
H.-D. Mennel
Affiliation:
Department of Neuropathology, University of Giessen and Marburg, Marburg, Germany
R. Engenhart-Cabillic
Affiliation:
Department of Radiotherapy and Radio-Oncology, University of Giessen and Marburg, Marburg, Germany
Get access Rights & Permissions [Opens in a new window]

Abstract

Purpose: To identify subgroups in glioblastoma multiforme (GBM) with different susceptibilities to radio-chemotherapy by p53 protein and Ki-67 expression.

Patients and Methods: Thirty-one patients with primary GBM underwent a combined radio-chemotherapy with topotecan. Percentage of cells expressing p53 protein and Ki-67 antigen was determined immunohistochemically. Additionally, the cell density within the tumour tissue was measured.

Results: Median percentages of p53 and Ki-67 expressing cells were 4.3% (range = 0–28%) and 12.0% (range = 0–28%), respectively. Dividing the cases into two groups by high or low p53 protein 1-year disease-free survival rates were 13.3% and 23.6%. High or low Ki-67 expression showed one-year disease-free survival rates of 18.8% and 17.1%. Neither p53 nor Ki-67 expression showed a significant correlation with disease-free survival or overall survival. Median cell density was 252 cells/field (range = 42–595). 1-year disease-free survival rates were 14.5% and 21.7% in high and low cell density group, respectively. A significant correlation with progression-free survival was observed, whereas the stratification into two groups revealed no significance. Cell density showed a significant inverse correlation with p53 and Ki-67 immunopositivity.

Conclusion:p53 protein and Ki-67 expression seem to be inappropriate for the estimation of prognosis in patients receiving a combined radio-chemotherapy with topotecan.

Keywords

p53Ki-67radio-chemotherapyprognostic factor
Type
Original Article
Information
Journal of Radiotherapy in Practice , Volume 5 , Issue 3 , September 2006 , pp. 165 - 172
Copyright
2006 Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)